IBDEI2WJ ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,46287,0)
 ;;=H21.232^^176^2304^29
 ;;^UTILITY(U,$J,358.3,46287,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46287,1,3,0)
 ;;=3^Degeneration of Iris,Pigmentary,Left Eye
 ;;^UTILITY(U,$J,358.3,46287,1,4,0)
 ;;=4^H21.232
 ;;^UTILITY(U,$J,358.3,46287,2)
 ;;=^5005188
 ;;^UTILITY(U,$J,358.3,46288,0)
 ;;=H57.00^^176^2304^30
 ;;^UTILITY(U,$J,358.3,46288,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46288,1,3,0)
 ;;=3^Anomaly of Pupillary Function,Unspec
 ;;^UTILITY(U,$J,358.3,46288,1,4,0)
 ;;=4^H57.00
 ;;^UTILITY(U,$J,358.3,46288,2)
 ;;=^5006375
 ;;^UTILITY(U,$J,358.3,46289,0)
 ;;=D31.42^^176^2304^31
 ;;^UTILITY(U,$J,358.3,46289,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46289,1,3,0)
 ;;=3^Benign Neopl of Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,46289,1,4,0)
 ;;=4^D31.42
 ;;^UTILITY(U,$J,358.3,46289,2)
 ;;=^5002125
 ;;^UTILITY(U,$J,358.3,46290,0)
 ;;=D31.41^^176^2304^32
 ;;^UTILITY(U,$J,358.3,46290,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46290,1,3,0)
 ;;=3^Benign Neopl of Ciliary Body,Right Eye
 ;;^UTILITY(U,$J,358.3,46290,1,4,0)
 ;;=4^D31.41
 ;;^UTILITY(U,$J,358.3,46290,2)
 ;;=^5002124
 ;;^UTILITY(U,$J,358.3,46291,0)
 ;;=C69.41^^176^2304^33
 ;;^UTILITY(U,$J,358.3,46291,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46291,1,3,0)
 ;;=3^Malig Neopl of Ciliary Body,Right Eye
 ;;^UTILITY(U,$J,358.3,46291,1,4,0)
 ;;=4^C69.41
 ;;^UTILITY(U,$J,358.3,46291,2)
 ;;=^5001279
 ;;^UTILITY(U,$J,358.3,46292,0)
 ;;=C69.42^^176^2304^34
 ;;^UTILITY(U,$J,358.3,46292,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46292,1,3,0)
 ;;=3^Malig Neopl of Ciliary Body,Left Eye
 ;;^UTILITY(U,$J,358.3,46292,1,4,0)
 ;;=4^C69.42
 ;;^UTILITY(U,$J,358.3,46292,2)
 ;;=^5001280
 ;;^UTILITY(U,$J,358.3,46293,0)
 ;;=H35.061^^176^2304^35
 ;;^UTILITY(U,$J,358.3,46293,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46293,1,3,0)
 ;;=3^Retinal Vasculitis,Right Eye
 ;;^UTILITY(U,$J,358.3,46293,1,4,0)
 ;;=4^H35.061
 ;;^UTILITY(U,$J,358.3,46293,2)
 ;;=^5005602
 ;;^UTILITY(U,$J,358.3,46294,0)
 ;;=H35.062^^176^2304^36
 ;;^UTILITY(U,$J,358.3,46294,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46294,1,3,0)
 ;;=3^Retinal Vasculitis,Left Eye
 ;;^UTILITY(U,$J,358.3,46294,1,4,0)
 ;;=4^H35.062
 ;;^UTILITY(U,$J,358.3,46294,2)
 ;;=^5005603
 ;;^UTILITY(U,$J,358.3,46295,0)
 ;;=H20.011^^176^2304^2
 ;;^UTILITY(U,$J,358.3,46295,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46295,1,3,0)
 ;;=3^Iridocyclitis,Primary,Right Eye
 ;;^UTILITY(U,$J,358.3,46295,1,4,0)
 ;;=4^H20.011
 ;;^UTILITY(U,$J,358.3,46295,2)
 ;;=^5005134
 ;;^UTILITY(U,$J,358.3,46296,0)
 ;;=H20.012^^176^2304^3
 ;;^UTILITY(U,$J,358.3,46296,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46296,1,3,0)
 ;;=3^Iridocyclitis,Primary,Left Eye
 ;;^UTILITY(U,$J,358.3,46296,1,4,0)
 ;;=4^H20.012
 ;;^UTILITY(U,$J,358.3,46296,2)
 ;;=^5005135
 ;;^UTILITY(U,$J,358.3,46297,0)
 ;;=H20.11^^176^2304^4
 ;;^UTILITY(U,$J,358.3,46297,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46297,1,3,0)
 ;;=3^Iridocyclitis,Chronic,Right Eye
 ;;^UTILITY(U,$J,358.3,46297,1,4,0)
 ;;=4^H20.11
 ;;^UTILITY(U,$J,358.3,46297,2)
 ;;=^5005155
 ;;^UTILITY(U,$J,358.3,46298,0)
 ;;=H20.12^^176^2304^5
 ;;^UTILITY(U,$J,358.3,46298,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,46298,1,3,0)
 ;;=3^Iridocyclitis,Chronic,Left Eye
 ;;^UTILITY(U,$J,358.3,46298,1,4,0)
 ;;=4^H20.12
 ;;^UTILITY(U,$J,358.3,46298,2)
 ;;=^5005156
 ;;^UTILITY(U,$J,358.3,46299,0)
 ;;=H21.551^^176^2304^16
